UBS Group »

Gain Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $249k 141k 1.77
2025-06-30 $59k 33k 1.80
2025-03-31 $83k 43k 1.91
2024-12-31 $71k 35k 2.00
2024-09-30 $15k 8.5k 1.78
2024-06-30 $15k 11k 1.28
2024-03-31 $33k 8.7k 3.77
2023-12-31 $46k 14k 3.27
2023-09-30 $27k 8.3k 3.29
2023-06-30 $42k 9.4k 4.48
2023-03-31 $21k 4.3k 4.82
2022-12-31 $23k 7.3k 3.13
2022-09-30 $0 4.1k 0.00
2022-06-30 $22k 6.4k 3.46
2022-03-31 $17k 4.1k 4.15
2021-12-31 $56k 11k 5.37
2021-09-30 $51k 6.7k 7.56
2021-06-30 $41k 4.1k 10.00
2021-03-31 $91k 6.1k 14.88